GF
Insider
Gregory R Friberg
EVP, Chief R&D OfficerGregory R Friberg (EVP, Chief R&D Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in BioMarin Pharmaceutical Inc. (BMRN). The largest single filing was $382K of BMRN (6,326 sh × $60.38, as filed), executed Feb 26.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$559K
shares × price, as filed
Last traded
May 7
Filed May 11
Median ADV $131.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $559K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
BMRNRecent filings
BMRNSALE
BioMarin Pharmaceutical Inc.
View filing →
$177K3,281 sh × $53.85
Exec May 7
Filed May 11 · 5:30 PM ET BMRNSALE BioMarin Pharmaceutical Inc. View filing → $382K
6,326 sh × $60.38
Exec Feb 26
Filed Feb 26 · 5:30 PM ET